SCHEMBL8282389

SCHEMBL8282389

Cc1nc(-c2ccc(N)c(F)c2)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ CA12 O43570 2/20 0.49
▸ CA1 P00915 2/20 0.49
▸ CA2 P00918 2/20 0.49
▸ CA9 Q16790 2/20 0.49
▸ PLK1 P53350 1/20 0.44
▸ AOC3 Q16853 2/20 0.44
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ MPO P05164 1/20 0.41
▸ BACE1 P56817 1/20 0.41
▸ BACE2 Q9Y5Z0 1/20 0.41
▸ NFKB1 P19838 2/20 0.40
▸ NFKB2 Q00653 2/20 0.40
▸ RELA Q04206 2/20 0.40
▸ LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8282433 0.87 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL14363620 0.85 L3MBTL1 (0.62) L3MBTL1CA12CA1CA2CA9
SCHEMBL15157090 0.85 L3MBTL1 (0.62) L3MBTL1CA12CA1CA2CA9
SCHEMBL7601476 0.83 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL25383050 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL12021744 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL25384005 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL27364860 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL8418331 0.80 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL3250198 0.80 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745047-B1 PYRAZOLO[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINE ADENOSINE-A2A- RECEPTOR ANTAGONISTS SCHERING CORP (US) 2010-03-24 — — EP disclosed
WO-2007035542-A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2007-03-29 — — WO disclosed
WO-2005103055-A1 PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2005-11-03 — — WO disclosed
Send feedback